Guided Therapeutics, Inc. (OTCMKTS:GTHP) Sees Significant Increase in Short Interest

Guided Therapeutics, Inc. (OTCMKTS:GTHP) was the recipient of a large growth in short interest in February. As of February 15th, there was short interest totalling 13,800 shares, a growth of 40.8% from the January 31st total of 9,800 shares. Based on an average daily volume of 28,200 shares, the short-interest ratio is currently 0.5 days.

Guided Therapeutics Stock Performance

Guided Therapeutics stock remained flat at $0.11 during midday trading on Monday. The company had a trading volume of 6 shares, compared to its average volume of 17,518. The firm has a market capitalization of $7.32 million, a P/E ratio of -3.74 and a beta of 0.61. The stock’s 50-day moving average price is $0.13 and its 200-day moving average price is $0.15. Guided Therapeutics has a twelve month low of $0.06 and a twelve month high of $0.23.

About Guided Therapeutics

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.